Arrive Health (formerly RxRevu) recently acquired a suite of technology developed at UPMC. The technology suite includes an AI-powered chatbot and customer relationship management platform, both designed to support improved medication adherence and prescription capture rates.
The company, which is called Infectious Disease (ID) Connect, aims to virtually connect UPMC infectious disease specialists to other hospitals.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Rasu Shrestha, UPMC's chief innovation officer and executive vice president of UPMC Enterprises, will join Atrium Health as its chief strategy officer in February 2019.
Though terms of the deal were not disclosed, the organizations said the combined company will serve almost 100 facilities in 14 states.
The Tus Science & Technology Service Group, an enterprise group in China, led the Series A round with participation from the commercialization arm of University of Pittsburgh Medical Center — UPMC Enterprises.
The president of UPMC's venture arm and it's innovation chief were among panelists explaining the benefits of having a hospital as an investor while asking for help from startups to transform the customer experience in healthcare.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Microsoft chose UPMC Enterprises as its initial innovation partner for Healthcare NExT as the Redmond Empire takes aim at the growing influence of IBM Watson Health, Salesforce, Apple's ResearchKit and other tech heavyweights.
UPMC Enterprises is the innovation and commercialization arm of the University of Pittsburgh Medical Center and it has launched about 60 healthcare companies to date.
Cernostics is part of the wave of oncology that looks at cancer at the tissue and cellular level instead of focusing on the location of the tumor — lung, stomach, pancreas.